logo
logo

Atonarp Announces $50M Series D Financing To Scale Its Molecular Sensing And Digital Diagnostics Testing Platforms

May 18, 2021•over 4 years ago

Amount Raised

$50 Million

Round Type

series d

Tokyo

Description

Atonarp, a leading manufacturer of molecular sensing and diagnostics products for the healthcare, pharma, and semiconductor industries, today announced it has raised a $50 million Series D financing, led by WRVI Capital. The new funding will allow the company to expand its operations to meet growing customer demand in its current markets and expedite the development and commercialization of its molecular diagnostics products. The company has announced the appointment of Shaun Holt as its chief operating officer (COO).

Company Information

Company

Atonarp

Location

Tokyo, Tokyo, Japan

About

Atonarp is a molecular diagnostics company reshaping how sensing and diagnostics devices are applied to generate real-time actionable data and achieve drastically better outcomes in healthcare and industrial semiconductor processes. Atonarp is led by a world-class team of experts in the design, development, and productization of highly sensitive diagnostics instruments. Founded in 2010, the company has operations in Japan, India, and the United States. Learn more at https://atonarp.com.

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech